Mainstay Medical International plc announced that Mr. Nael Karim Kassar and Mr. Greg Garfield will be appointed as Directors immediately following completion of the Placing, which is expected to occur on June 17, 2016. Nael Karim Kassar is a director of KCK. Nael does not currently have any interest in Ordinary Shares save for the interest to be acquired by KCK under the Placing. Nael has a beneficial interest of 10% in the issued share capital of KCK. Greg Shaw Garfield is an experienced medical technology executive. Greg does not currently have any interest in Ordinary Shares, save for the interest to be acquired by KCK under the Placing. Greg was a non-executive director of Sonitus Medical Inc. until January 2015, when the company entered into a voluntary liquidation. The liquidation was completed in January 2016.